Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 63

1.

Recurrent hyperactive ESR1 fusion proteins in endocrine therapy-resistant breast cancer.

Hartmaier RJ, Trabucco SE, Priedigkeit N, Chung JH, Parachoniak CA, Vanden Borre P, Morley S, Rosenzweig M, Gay LM, Goldberg ME, Suh J, Ali SM, Ross J, Leyland-Jones B, Young B, Williams C, Park B, Tsai M, Haley B, Peguero J, Callahan RD, Sachelarie I, Cho J, Atkinson JM, Bahreini A, Nagle AM, Puhalla SL, Watters RJ, Erdogan-Yildirim Z, Cao L, Oesterreich S, Mathew A, Lucas PC, Davidson NE, Brufsky AM, Frampton GM, Stephens PJ, Chmielecki J, Lee AV.

Ann Oncol. 2018 Apr 1;29(4):872-880. doi: 10.1093/annonc/mdy025.

2.

Endophilin B2 facilitates endosome maturation in response to growth factor stimulation, autophagy induction, and influenza A virus infection.

Serfass JM, Takahashi Y, Zhou Z, Kawasawa YI, Liu Y, Tsotakos N, Young MM, Tang Z, Yang L, Atkinson JM, Chroneos ZC, Wang HG.

J Biol Chem. 2017 Jun 16;292(24):10097-10111. doi: 10.1074/jbc.M117.792747. Epub 2017 Apr 28.

PMID:
28455444
3.

Acute Exercise and Appetite-Regulating Hormones in Overweight and Obese Individuals: A Meta-Analysis.

Douglas JA, Deighton K, Atkinson JM, Sari-Sarraf V, Stensel DJ, Atkinson G.

J Obes. 2016;2016:2643625. doi: 10.1155/2016/2643625. Epub 2016 Dec 27. Review.

4.

Atg5-dependent autophagy contributes to the development of acute myeloid leukemia in an MLL-AF9-driven mouse model.

Liu Q, Chen L, Atkinson JM, Claxton DF, Wang HG.

Cell Death Dis. 2016 Sep 8;7(9):e2361. doi: 10.1038/cddis.2016.264.

5.

Translational Pharmacokinetic-Pharmacodynamic Modeling and Simulation: Optimizing 5-Fluorouracil Dosing in Children With Pediatric Ependymoma.

Daryani VM, Patel YT, Tagen M, Turner DC, Carcaboso AM, Atkinson JM, Gajjar A, Gilbertson RJ, Wright KD, Stewart CF.

CPT Pharmacometrics Syst Pharmacol. 2016 Apr;5(4):211-221. doi: 10.1002/psp4.12075. Epub 2016 Apr 14.

6.

Activating the Wnt/β-Catenin Pathway for the Treatment of Melanoma--Application of LY2090314, a Novel Selective Inhibitor of Glycogen Synthase Kinase-3.

Atkinson JM, Rank KB, Zeng Y, Capen A, Yadav V, Manro JR, Engler TA, Chedid M.

PLoS One. 2015 Apr 27;10(4):e0125028. doi: 10.1371/journal.pone.0125028. eCollection 2015.

7.

Inhibition of Thrombin-Activated Fibrinolysis Inhibitor Increases Survival in Experimental Kidney Fibrosis.

Atkinson JM, Pullen N, Da Silva-Lodge M, Williams L, Johnson TS.

J Am Soc Nephrol. 2015 Aug;26(8):1925-37. doi: 10.1681/ASN.2014030303. Epub 2014 Nov 19.

8.

Development and validation of a new bariatric-specific health-related quality of life instrument ''bariatric and obesity-specific survey (BOSS)''.

Tayyem RM, Atkinson JM, Martin CR.

J Postgrad Med. 2014 Oct-Dec;60(4):357-61. doi: 10.4103/0022-3859.143952.

9.

Tumor-targeted prodrug ICT2588 demonstrates therapeutic activity against solid tumors and reduced potential for cardiovascular toxicity.

Gill JH, Loadman PM, Shnyder SD, Cooper P, Atkinson JM, Ribeiro Morais G, Patterson LH, Falconer RA.

Mol Pharm. 2014 Apr 7;11(4):1294-300. doi: 10.1021/mp400760b. Epub 2014 Mar 27.

PMID:
24641451
10.

Identification of risk factors associated with acute kidney injury in patients admitted to acute medical units.

Finlay S, Bray B, Lewington AJ, Hunter-Rowe CT, Banerjee A, Atkinson JM, Jones MC.

Clin Med (Lond). 2013 Jun;13(3):233-8. doi: 10.7861/clinmedicine.13-3-233.

PMID:
23760694
11.

An inhibitor of thrombin activated fibrinolysis inhibitor (TAFI) can reduce extracellular matrix accumulation in an in vitro model of glucose induced ECM expansion.

Atkinson JM, Pullen N, Johnson TS.

Matrix Biol. 2013 Jun 24;32(5):277-87. doi: 10.1016/j.matbio.2013.01.006. Epub 2013 Jan 29.

PMID:
23369837
12.

Improving the efficiency of selection to Core Medical Training: a study of the use of multiple assessment stations.

Atkinson JM, Tullo E, Mitchison H, Pearce MS, Kumar N.

J R Coll Physicians Edinb. 2012 Jun;42(2):101-5. doi: 10.4997/JRCPE.2012.202.

PMID:
22693691
13.

Developing treatment strategies for rare cancers.

Atkinson JM, Gilbertson RJ.

Oncotarget. 2011 Sep;2(9):657. No abstract available.

14.

An integrated in vitro and in vivo high-throughput screen identifies treatment leads for ependymoma.

Atkinson JM, Shelat AA, Carcaboso AM, Kranenburg TA, Arnold LA, Boulos N, Wright K, Johnson RA, Poppleton H, Mohankumar KM, Féau C, Phoenix T, Gibson P, Zhu L, Tong Y, Eden C, Ellison DW, Priebe W, Koul D, Yung WK, Gajjar A, Stewart CF, Guy RK, Gilbertson RJ.

Cancer Cell. 2011 Sep 13;20(3):384-99. doi: 10.1016/j.ccr.2011.08.013.

15.

A Tool to Assess Compliance in Anticoagulation Management.

Huber CS, Levett JM, Atkinson JM.

In: Henriksen K, Battles JB, Keyes MA, Grady ML, editors. Advances in Patient Safety: New Directions and Alternative Approaches (Vol. 3: Performance and Tools). Rockville (MD): Agency for Healthcare Research and Quality (US); 2008 Aug.

16.
17.

Development of a novel tumor-targeted vascular disrupting agent activated by membrane-type matrix metalloproteinases.

Atkinson JM, Falconer RA, Edwards DR, Pennington CJ, Siller CS, Shnyder SD, Bibby MC, Patterson LH, Loadman PM, Gill JH.

Cancer Res. 2010 Sep 1;70(17):6902-12. doi: 10.1158/0008-5472.CAN-10-1440. Epub 2010 Jul 27.

18.

The content of mental health advance directives: Advance statements in Scotland.

Reilly J, Atkinson JM.

Int J Law Psychiatry. 2010 Mar-Apr;33(2):116-21. doi: 10.1016/j.ijlp.2009.12.002. Epub 2010 Jan 13.

PMID:
20074806
19.

Management of acute ischaemic stroke in the acute medical unit.

Atkinson JM, Barton L, Price CI.

Acute Med. 2010;9(3):99-103.

PMID:
21597587
20.

Tumour endoproteases: the cutting edge of cancer drug delivery?

Atkinson JM, Siller CS, Gill JH.

Br J Pharmacol. 2008 Apr;153(7):1344-52. doi: 10.1038/sj.bjp.0707657. Epub 2008 Jan 21. Review.

21.

Outcome following clozapine discontinuation: a retrospective analysis.

Atkinson JM, Douglas-Hall P, Fischetti C, Sparshatt A, Taylor DM.

J Clin Psychiatry. 2007 Jul;68(7):1027-30.

PMID:
17685738
22.

Membrane type matrix metalloproteinases (MMPs) show differential expression in non-small cell lung cancer (NSCLC) compared to normal lung: correlation of MMP-14 mRNA expression and proteolytic activity.

Atkinson JM, Pennington CJ, Martin SW, Anikin VA, Mearns AJ, Loadman PM, Edwards DR, Gill JH.

Eur J Cancer. 2007 Jul;43(11):1764-71. Epub 2007 Jun 27.

PMID:
17600697
23.

Academic medicine: who is it for? Wider discussions are needed.

Atkinson JM.

BMJ. 2005 Feb 12;330(7487):360; discussion 363-4. No abstract available.

24.

Models of advance directives in mental health care: stakeholder views.

Atkinson JM, Garner HC, Gilmour WH.

Soc Psychiatry Psychiatr Epidemiol. 2004 Aug;39(8):673-80.

PMID:
15300379
25.

Prevalence and experience of harassment of people with mental health problems living in the community.

Berzins KM, Petch A, Atkinson JM.

Br J Psychiatry. 2003 Dec;183:526-33.

PMID:
14645024
26.

Undisclosed payments in research. Patients have the right to know motivations of researchers.

Atkinson JM.

BMJ. 2002 Nov 16;325(7373):1174. No abstract available.

27.

Training nurses to support carers of relatives with schizophrenia.

Gall SH, Elliott L, Atkinson JM, Johansen R.

Br J Nurs. 2001 Feb 22-Mar 7;10(4):238-41.

PMID:
12170648
28.

Does writing a list help cancer patients ask relevant questions?

Jones R, Pearson J, McGregor S, Barrett A, Harper Gilmour W, Atkinson JM, Cawsey AJ, McEwen J.

Patient Educ Couns. 2002 Aug;47(4):369-71.

PMID:
12135829
29.

Randomised trial of personalised computer based information for patients with schizophrenia.

Jones RB, Atkinson JM, Coia DA, Paterson L, Morton AR, McKenna K, Craig N, Morrison J, Gilmour WH.

BMJ. 2001 Apr 7;322(7290):835-40. Erratum in: BMJ 2001 May 5;322(7294):1103.

30.

Cross sectional survey of patients' satisfaction with information about cancer.

Jones R, Pearson J, McGregor S, Gilmour WH, Atkinson JM, Barrett A, Cawsey AJ, McEwen J.

BMJ. 1999 Nov 6;319(7219):1247-8. No abstract available.

31.

Randomised trial of personalised computer based information for cancer patients.

Jones R, Pearson J, McGregor S, Cawsey AJ, Barrett A, Craig N, Atkinson JM, Gilmour WH, McEwen J.

BMJ. 1999 Nov 6;319(7219):1241-7.

32.

The impact of education groups for people with schizophrenia on social functioning and quality of life.

Atkinson JM, Coia DA, Gilmour WH, Harper JP.

Br J Psychiatry. 1996 Feb;168(2):199-204.

PMID:
8837910
33.

Orthognathic surgery: patient expectations; psychological profile and satisfaction with outcome.

Finlay PM, Atkinson JM, Moos KF.

Br J Oral Maxillofac Surg. 1995 Feb;33(1):9-14.

PMID:
7718535
34.

Reinventing public health.

Polangin RF, Atkinson JM.

J Fla Med Assoc. 1994 Aug;81(8):549-51. No abstract available.

PMID:
7964583
35.

Superhealth basic: Development and evaluation of a low-cost community-based lifestyle change programme.

Raeburn JM, Atkinson JM, Dubignon JM, Fitzpatrick J, McPherson M, Elkind GS.

Psychol Health. 1994 Jul;9(5):383-395. doi: 10.1080/08870449408407496.

PMID:
29022395
36.

The patient as sufferer.

Atkinson JM.

Br J Med Psychol. 1993 Jun;66 ( Pt 2):113-20.

PMID:
8353105
37.

Male obstetricians and their patients.

Atkinson JM.

BMJ. 1993 Mar 27;306(6881):861. No abstract available.

38.
39.

Stress and the dental surgery assistant.

Atkinson JM.

Br Dent Surg Assist. 1992 Winter;51(4):4-5. No abstract available.

PMID:
1308146
40.

Mechanism of inhibition of hepatic bile acid uptake by amiloride and 4,4'-diisothiocyano-2,2'-disulfonic stilbene (DIDS).

Anwer MS, Branson AU, Atkinson JM.

Biochem Pharmacol. 1991 Dec 11;42 Suppl:S135-41.

PMID:
1768270
41.

'Beam them up, Scotty!'.

Atkinson JM.

Br J Psychiatry. 1991 Aug;159:292. No abstract available.

PMID:
1812879
42.

The prevention of dental disease: changing your patients' behaviour.

Kay EJ, Millar K, Blinkhorn AS, Atkinson JM.

Dent Update. 1991 Jul-Aug;18(6):245-8.

PMID:
1810775
43.

Stress in dental practice.

Atkinson JM, Millar K, Kay EJ, Blinkhorn AS.

Dent Update. 1991 Mar;18(2):60-4.

PMID:
1915991
44.

Helping anxious adult patients.

Millar K, Atkinson JM, Blinkhorn AS, Kay EJ.

Dent Update. 1991 Jan-Feb;18(1):18, 20-2, 24-5. No abstract available.

PMID:
1936426
45.

Advice for the dental team on coping with the nervous child.

Blinkhorn AS, Kay EJ, Atkinson JM, Millar K.

Dent Update. 1990 Dec;17(10):415-9.

PMID:
2088793
46.

Amiloride and taurine inhibit cholate-induced HCO3(-)-rich choleresis in perfused rat livers.

Anwer MS, Atkinson JM, Zimniak P.

Am J Physiol. 1990 Sep;259(3 Pt 1):G453-61.

PMID:
2169205
47.

Ursodeoxycholate-induced changes in hepatic Na+-H+ exchange and biliary HCO3- excretion.

Anwer MS, Hondalus MK, Atkinson JM.

Am J Physiol. 1989 Sep;257(3 Pt 1):G371-9.

PMID:
2551181
48.

To tell or not to tell the diagnosis of schizophrenia.

Atkinson JM.

J Med Ethics. 1989 Mar;15(1):21-4.

49.

A new method of photo-documentation for the follow-up of dysplastic naevi.

Atkinson JM, From L, Boyer R.

J Audiov Media Med. 1987 Jan;10(1):12-4. No abstract available.

PMID:
3668166
50.

A low-cost community approach to weight control: initial results from an evaluated trial.

Raeburn JM, Atkinson JM.

Prev Med. 1986 Jul;15(4):391-402.

PMID:
3763562

Supplemental Content

Loading ...
Support Center